Whole grains may improve several heart risk factors at once
Light exposure at night may raise risk for heart disease
Children of centenarians may stay healthier and live longer too, study finds
A lumbar belt may help ease low back pain
Signs of pneumonia: Sometimes vague and unexpected
The surprising link between ovarian cancer and the fallopian tubes
Using a vibration plate: What it can — and can't — do for your body
People who walk more or walk faster live longer, study finds
Rosacea treatments: What works?
For sleep apnea, a dental device may be as effective as CPAP
Sarah Wakeman, MD, FASAM
Contributor
Dr. Sarah Wakeman is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team and a clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate of the American Board of Addiction Medicine. She is secretary for the Massachusetts Society of Addiction Medicine and chair of the policy committee. She previously served on Governor Baker’s Opioid Addiction Working Group.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her active research projects include a study evaluating the impact of addiction consultation on hospitalized medical patients with substance use disorder; a qualitative study exploring the role of recovery coaches for patients with substance use disorder; the healthcare cost and utilization impact of increased addiction treatment services across a health system; and the impact of a hospital-wide substance use disorder initiative on physician attitudes, preparedness, and clinical practice related to substance use disorder.
Posts by Sarah Wakeman, MD, FASAM
Sarah Wakeman, MD, FASAM
Lofexidine: Another option for withdrawal from opioids, but is it better?
Sarah Wakeman, MD, FASAM
Saving lives by prescribing naloxone with opioid painkillers
Sarah Wakeman, MD, FASAM
Fentanyl: The dangers of this potent “man-made” opioid
Whole grains may improve several heart risk factors at once
Light exposure at night may raise risk for heart disease
Children of centenarians may stay healthier and live longer too, study finds
A lumbar belt may help ease low back pain
Signs of pneumonia: Sometimes vague and unexpected
The surprising link between ovarian cancer and the fallopian tubes
Using a vibration plate: What it can — and can't — do for your body
People who walk more or walk faster live longer, study finds
Rosacea treatments: What works?
For sleep apnea, a dental device may be as effective as CPAP